Looking at their schedule, it’s not going to work. They have a tough road with really good defenses. Philip is a sitting duck ...

The ASX healthcare sector has logged another week in the red and, without a Christmas miracle, looks set to end 2025 as the ...

Because it causes tissue damage and tissue death in the legs, feet, and toes, PAD is implicated in 150,000 lower-limb ...

("Profusa” or the "Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation ...

More than a dozen schools in the Edmonton metropolitan region are dealing with an outbreak of illness, according to a number ...

Pangram, already established as the most accurate and most reliable AI transparency and discovery technology, today launched a significant new upgrade to its detection software ? Pangram 3.0. Pangram ...

U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...

Zurletrectinib has been included in the “SPARK Program” by China’s National Medical Products Administration (NMPA), a pilot initiative to encourage the development of pediatric anti-tumor drugs.

Adagio Medical Holdings, Inc ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been ...

Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight ...

TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week ...

A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, ...